- Home
- FBLA vs FULC Comparison
FBLA vs FULC Comparison
Compare FBLA & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLA
- FULC
- Stock Information
- Founded
- FBLA N/A
- FULC 2015
- Country
- FBLA
- FULC United States
- Employees
- FBLA N/A
- FULC N/A
- Industry
- FBLA
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- FBLA
- FULC Health Care
- Exchange
- FBLA NYSE
- FULC Nasdaq
- Market Cap
- FBLA 239.0M
- FULC 221.5M
- IPO Year
- FBLA N/A
- FULC 2019
- Fundamental
- Price
- FBLA $12.19
- FULC $3.49
- Analyst Decision
- FBLA
- FULC Hold
- Analyst Count
- FBLA 0
- FULC 10
- Target Price
- FBLA N/A
- FULC $7.44
- AVG Volume (30 Days)
- FBLA N/A
- FULC 663.1K
- Earning Date
- FBLA N/A
- FULC 11-13-2024
- Dividend Yield
- FBLA N/A
- FULC N/A
- EPS Growth
- FBLA N/A
- FULC N/A
- EPS
- FBLA N/A
- FULC N/A
- Revenue
- FBLA N/A
- FULC $81,630,000.00
- Revenue This Year
- FBLA N/A
- FULC $2,821.96
- Revenue Next Year
- FBLA N/A
- FULC N/A
- P/E Ratio
- FBLA N/A
- FULC N/A
- Revenue Growth
- FBLA N/A
- FULC 2582.55
- 52 Week Low
- FBLA N/A
- FULC $2.87
- 52 Week High
- FBLA N/A
- FULC $13.70
- Technical
- Relative Strength Index (RSI)
- FBLA N/A
- FULC 44.97
- Support Level
- FBLA N/A
- FULC $3.13
- Resistance Level
- FBLA N/A
- FULC $3.63
- Average True Range (ATR)
- FBLA 0.00
- FULC 0.16
- MACD
- FBLA 0.00
- FULC 0.11
- Stochastic Oscillator
- FBLA 0.00
- FULC 72.58
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.